Related Experiment Video

Updated: Apr 26, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

8.4K

Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV

, Rosa Polo Rodríguez, María José Galindo Puerto

    Enfermedades Infecciosas Y Microbiologia Clinica
    |August 7, 2014
    PubMed

    Insights

    Metabolic disorders and cardiovascular risks are significant concerns for individuals with HIV. Managing these conditions requires individualized care, focusing on drug selection and lifestyle changes for better patient outcomes.

    Area of Science:

    • Infectious Diseases
    • Endocrinology
    • Cardiology

    Background:

    • Human Immunodeficiency Virus (HIV) infection independently elevates cardiovascular risk.
    • HIV patients share common cardiovascular risk factors with the general population.
    • Antiretroviral therapy can introduce or exacerbate metabolic disorders, adding to cardiovascular risk.

    Framework:

    • Prioritizes selecting antiretroviral drugs with favorable metabolic profiles.
    • Emphasizes managing common metabolic disorders (insulin resistance, diabetes, hyperlipidemia, osteopenia) in HIV patients.
    • Recommends applying general population guidelines for hypertension management in HIV-positive individuals.

    Implementation:

    • Highlights the need for continuous study and updating of management strategies.
    • Advocates for integrating healthier lifestyle recommendations.
    • Provides a query tool for healthcare professionals treating HIV patients with metabolic disorders.

    Implications:

    • Aims to improve the cardiovascular health of HIV-infected patients.
    • Supports evidence-based, individualized patient care.
    • Facilitates better clinical decision-making for managing complex comorbidities in HIV.

    Keywords:
    Alteraciones metabólicasCardiovascular riskHIV infectionInfección por VIHMetabolic disordersRiesgo cardiovascular

    More Related Videos

    Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

    Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

    Published on: September 26, 2018

    7.1K
    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings19:57

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

    Published on: March 30, 2014

    19.2K

    Related Concept Videos

    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    888
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    701
    Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

    Cardiovascular Drugs: Classification based on Therapeutic Indications

    Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
    4.2K
    Rheumatic Heart Disease III: Medical Management01:21

    Rheumatic Heart Disease III: Medical Management

    Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
    534
    Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

    Hypertension III: Clinical Manifestations and Diagnostic Studies

    Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
    825
    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
    1.8K